Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Cuminaldehyde

SKU: orb1299816

Description

Cuminaldehyde is a naturally occurring aromatic aldehyde that inhibits alpha-synuclein fibrillation and cytotoxicity. It exhibits anticancer properties in vitro and is a key fragrant component of essential oils, making it relevant for neurodegenerative and oncology research.

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number122-03-2
MW148.2
Purity98.00% (May vary between batches)
FormulaC10H12O
SMILESCC(C)c1ccc(C=O)cc1
TargetEndogenous Metabolite
SolubilityDMSO:25 mg/mL (168.69 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (13.5 mM)

Bioactivity

In Vivo
In vivo, cuminaldehyde diminished the tumor burden ,cuminaldehyde could be a drug for chemopreventive or anticancer therapy
In Vitro
Cuminaldehyde suppressed growth and induced apoptosis, as proved by depletion of the mitochondrial membrane potential, activation of both caspase-3 and -9, and morphological features of apoptosis.
Cell Research
Incubated the cells in the culture plate with 96 wells at the concentration of ten thousand cells per well. After being incubated for 24 h, we treated the cells with cuminaldehyde at the concentration of 10, 20, 40, 80, or 160 μM for 12, 24, or 48 h. Determined cell viability using the Cell Proliferation Kit II (XTT) according to the supplier's instructions. The value of absorbance was evaluated by a spectrophotometer (Tecan infinite M200, Tecan, M nnedorf, Switzerland) using 492 nm wavelength with a reference of 650 nm wavelength.
Animal Research
Human colorectal COLO 205 cells (5 × 10^6 cells in 200 μL of culture medium) were subcutaneously injected into the mice's flanks. Treatment was started when the tumors reached about 75 mm^3. Thirty-two mice were divided randomly into four groups (eight mice/group). Cuminaldehyde-treated mice received intratumoral injection of 5, 10, or 20 mg/kg/day of cuminaldehyde in a 200 μL volume (the solutions were prepared from stock solution of cuminaldehyde in dimethyl sulfoxide and diluted into appropriate concentrations in PBS) daily. The mice in the control group were treated with an equal volume of vehicle. After transplantation, body weight as well as tumor size were monitored at weekly intervals. Tumor size was measured using calipers, and tumor volume was calculated using the hemiellipsoid model formula

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Cuminal, Cuminaldehyde, Cuminic aldehyde, inhibit, Endogenous Metabolite, EndogenousMetabolite, Inhibitor

Similar Products

  • Cuminaldehyde [orb1220340]

    >98% (HPLC)

    122-03-2

    148.2

    C10H12O

    100 mg, 500 mg, 1 g, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
$ 70.00
5 g
$ 90.00
10 g
$ 110.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry